Arcus Biosciences, Inc. - Laporan Laba Rugi (TTM)

Arcus Biosciences, Inc.
US ˙ NYSE ˙ US03969F1093

Laporan Laba Rugi (TTM)

Laporan Laba Rugi Arcus Biosciences, Inc. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 78 78 85 93 38 383 392 409 433 112 119 121 120 117 237 247 263 258 141 262
Change (%) 0.28 9.27 9.05 -59.25 911.35 2.23 4.48 5.75 -74.11 6.25 1.68 -0.83 -2.50 102.56 4.22 6.48 -1.90 -45.35 85.82
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 131 159 203 236 255 29 252 253 259 288 -19 322 327 340 368 399 440 448 461 485
Change (%) 21.08 27.42 16.33 8.25 -88.63 767.63 0.49 2.27 11.37 -106.60 -1,794.74 1.55 3.98 8.24 8.42 10.28 1.82 2.90 5.21
% of Revenue 168.84 203.85 237.71 253.58 673.68 7.57 64.26 61.81 59.77 257.14 -15.97 266.12 272.50 290.60 155.27 161.54 167.30 173.64 326.95 185.11
Gross Operating Profit -54 -81 -117 -143 -217 354 140 156 174 -176 138 126 120 -223 -131 -152 -177 -190 -320 -223
Change (%) 51.28 44.90 21.61 52.21 -262.94 -60.47 11.66 11.39 -201.13 -178.41 -8.70 -4.76 -285.83 -41.26 16.03 16.45 7.34 68.42 -30.31
% of Revenue -68.84 -103.85 -137.71 -153.58 -573.68 92.43 35.74 38.19 40.23 -157.14 115.97 104.13 100.00 -190.60 -55.27 -61.54 -67.30 -73.64 -226.95 -85.11
SG&A 36 43 51 57 62 72 80 89 99 104 110 112 116 117 119 121 121 120 116 115
Change (%) 18.76 19.11 10.53 9.13 16.55 11.36 11.44 10.81 5.04 5.77 1.82 3.57 0.86 1.71 1.68 0.00 -0.83 -3.33 -0.86
% of Revenue 46.55 55.13 60.09 60.91 163.13 18.80 20.48 21.84 22.89 92.86 92.44 92.56 96.67 100.00 50.21 48.99 46.01 46.51 82.27 43.89
R&D 228 327 327 327
Change (%) 0.00 0.00
% of Revenue 59.53 274.79 270.25 272.50
OpEx 168 202 254 292 317 329 332 342 358 392 418 434 443 457 487 520 561 568 577 600
Change (%) 20.58 25.65 15.16 8.42 3.82 0.85 3.14 4.50 9.62 6.63 3.83 2.07 3.16 6.56 6.78 7.88 1.25 1.58 3.99
% of Revenue 215.39 258.97 297.80 314.49 836.81 85.90 84.74 83.65 82.66 350.00 351.26 358.68 369.17 390.60 205.49 210.53 213.31 220.16 409.22 229.01
Operating Income -90 -124 -169 -199 -279 54 60 67 75 -280 -299 -313 -323 -340 -250 -273 -298 -310 -436 -338
Change (%) 38.16 35.95 18.25 39.98 -119.35 10.64 11.94 12.16 -473.24 6.79 4.68 3.19 5.26 -26.47 9.20 9.16 4.03 40.65 -22.48
% of Revenue -115.39 -158.97 -197.80 -214.49 -736.81 14.10 15.26 16.35 17.34 -250.00 -251.26 -258.68 -269.17 -290.60 -105.49 -110.53 -113.31 -120.16 -309.22 -129.01
Interest Expense -1 -1 -2 -3 -2 -3 -2 -2 -2 -2 -4 -4 -6
Change (%) -0.00 100.00 50.00 -33.33 50.00 -33.33 -0.00 -0.00 -0.00 100.00 -0.00 50.00
% of Revenue -0.24 -0.23 -1.79 -2.52 -1.65 -2.50 -1.71 -0.84 -0.81 -0.76 -1.55 -2.84 -2.29
Net Income -88 -123 -168 -199 -278 53 58 67 80 -267 -279 -287 -293 -307 -231 -249 -270 -283 -391 -298
Change (%) 40.41 36.34 18.42 40.18 -119.04 8.67 15.57 19.49 -435.69 4.49 2.87 2.09 4.78 -24.76 7.79 8.43 4.81 38.16 -23.79
% of Revenue -112.63 -157.69 -196.76 -213.68 -735.12 13.84 14.71 16.27 18.39 -238.39 -234.45 -237.19 -244.17 -262.39 -97.47 -100.81 -102.66 -109.69 -277.30 -113.74

Source: Capital IQ

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista